A point-prevalence study of off-label medication use in an Australian adult tertiary intensive care unit

Medications prescribed for indications or at doses, frequencies or durations not approved by the Australian Therapeutic Goods Administration are considered “off- label”. Critical illness makes seeking consent for off-label medication use impractical. We aimed to characterise the extent of off-label...

Descripción completa

Detalles Bibliográficos
Autores principales: Wiebe, Jordan, Lipman, Jeffrey, Reade, Michael C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10692588/
https://www.ncbi.nlm.nih.gov/pubmed/38045597
http://dx.doi.org/10.51893/2022.2.OA8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10692588/
https://www.ncbi.nlm.nih.gov/pubmed/38045597
http://dx.doi.org/10.51893/2022.2.OA8

Ejemplares similares